Medical therapy for benign prostatic hyperplasia

This publication has 76 references indexed in Scilit:

• The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasia
  The Prostate, 1993
• The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia
  The Prostate, 1993
• The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle
  The Prostate, 1992
• Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
  New England Journal of Medicine, 1991
• Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic intervention
  The Prostate, 1990
• Selective inhibition of androstenedione‐induced prostate growth in intact beagle dogs by a combined treatment with the antiandrogen cyproterone acetate and the aromatase inhibitor 1‐methyl‐androsta‐1,4‐diene‐3,17‐dione (1‐methyl‐ADD)
  The Prostate, 1989
• Response of the Benign Hypertrophied Prostate to Treatment with an LHRH Analogue
  British Journal of Urology, 1988
• The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic Hyperplasia
  New England Journal of Medicine, 1987
• Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled Study
  British Journal of Urology, 1987
• THE RESULTS OF DOUBLE CASTRATION IN HYPERTROPHY OF THE PROSTATE
  Annals of Surgery, 1895